Neurological
circa 400 BCE, ancient Greece — Hippocratic Corpus (descriptions of progressive limb paralysis attributed to phlegmatic humoral corruption of nervous pathways)
Chronic inflammatory demyelinating polyneuropathy, a condition involving progressive damage to peripheral nerve myelin sheaths that historical observers recognized through its manifestations of gradual limb weakness and sensory disturbance, resisted clear categorization until the twentieth century produced the tools of electrodiagnostics and nerve biopsy. Earlier physicians grouped it within broad categories of paralytic disease or ascribed it to constitutional debility, toxic exposure, or syphilitic degeneration. Its emergence as a distinct entity depended on the slow accumulation of neuropathological and immunological understanding across more than a century of scientific inquiry.
Historical Narrative
The ancient medical traditions offered no specific category corresponding to chronic inflammatory demyelinating polyneuropathy, but they recorded observations of progressive limb weakness and sensory loss that physicians attributed to humoral imbalances affecting the nerves. Hippocratic writers described conditions of spreading paralysis under terms such as paraplegia and paresis, attributing them to phlegm or cold corrupting the nervous pathways. Galen, who conducted extensive dissections of animal nervous systems and articulated a sophisticated if erroneous theory of neural pneuma — a vital spirit flowing through hollow nerves — described peripheral nerve dysfunction as a failure of this pneumatic supply.
Medieval Islamic physicians, particularly Avicenna in his Canon of Medicine completed around 1025 CE, systematized Greek neurological theory and described various forms of weakness and sensory loss affecting the limbs. These descriptions remained theoretical elaborations on Galenic foundations rather than advances toward understanding immune-mediated demyelination, a concept that required both cellular pathology and immunology to become even imaginable.
The eighteenth and early nineteenth centuries produced the first important conceptual separations within the broad category of paralytic disease. Scottish anatomist Charles Bell and French physiologist François Magendie independently established in the 1810s and 1820s that spinal nerve roots carried distinct motor and sensory functions — Bell demonstrating motor function of anterior roots, Magendie confirming both motor and sensory distinctions. This Bell-Magendie Law created the essential conceptual framework for thinking about peripheral nerve dysfunction in more precise anatomical terms.
The later nineteenth century saw neuropathology emerge as a distinct discipline. Jean-Martin Charcot at the Salpêtrière in Paris conducted landmark post-mortem examinations correlating neurological findings during life with tissue appearances after death. Charcot and his colleagues described several distinct peripheral nerve diseases, and his work helped separate conditions affecting peripheral nerves from those affecting the spinal cord. Charcot's pupil Joseph Babinski and contemporaries such as Pierre Marie refined clinical descriptions of peripheral neuropathy, while German neuropathologists including Wilhelm Erb contributed to systematic classification of polyneuropathies.
The concept of myelin and its disruption became accessible after Rudolf Virchow identified and named the myelin sheath in the mid-nineteenth century, and after Louis-Antoine Ranvier described the nodes along myelinated fibers that now bear his name. These structural discoveries made it possible to envision demyelination as a pathological process, though the specific immune mechanism behind inflammatory demyelination remained opaque.
In the early twentieth century, clinicians began distinguishing a subgroup of patients with chronic, relapsing, or slowly progressive peripheral neuropathy that differed in course and pathology from acute Guillain-Barré syndrome, which had been described by Georges Guillain, Jean Alexandre Barré, and André Strohl in 1916. The formal delineation of chronic inflammatory demyelinating polyneuropathy as a separate entity crystallized through the work of Peter James Dyck and his colleagues at the Mayo Clinic in the 1970s and early 1980s. Dyck's systematic use of nerve conduction studies, nerve biopsy, and longitudinal clinical observation allowed him and his collaborators to define diagnostic criteria that separated this chronic condition from acute inflammatory neuropathy and hereditary demyelinating diseases, establishing the nosological category that subsequent decades of immunological and genetic research then proceeded to investigate.
Key Historical Figures
Historical narrative only — this page describes how Chronic inflammatory demyelinating polyneuropathy was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.